The inhibitory effect of salmon calcitonin on tri-iodothyronine induction of early hypertrophy in articular cartilage.
Salmon calcitonin has chondroprotective effect both in vitro and in vivo, and is therefore being tested as a candidate drug for cartilage degenerative diseases. Recent studies have indicated that different chondrocyte phenotypes may express the calcitonin receptor (CTR) differentially. We tested for...
Main Authors: | Pingping Chen-An, Kim Vietz Andreassen, Kim Henriksen, Yadong Li, Morten Asser Karsdal, Anne-Christine Bay-Jensen |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3386925?pdf=render |
Similar Items
-
The Impact of Exposure Profile on the Efficacy of Dual Amylin and Calcitonin Receptor Agonist Therapy
by: Nina Sonne, et al.
Published: (2022-09-01) -
Investigation of the direct effects of salmon calcitonin on human osteoarthritic chondrocytes
by: Pedersen Christian, et al.
Published: (2010-04-01) -
Biochemical markers identify influences on bone and cartilage degradation in osteoarthritis - the effect of sex, Kellgren-Lawrence (KL) score, Body Mass Index (BMI), oral salmon calcitonin (sCT) treatment and diurnal variation
by: Henriksen K, et al.
Published: (2010-06-01) -
The minor collagens in articular cartilage
by: Yunyun Luo, et al.
Published: (2017-02-01) -
Mono and dual agonists of the amylin, calcitonin, and CGRP receptors and their potential in metabolic diseases
by: Nina Sonne, et al.
Published: (2021-04-01)